Palonosetron Hydrochloride CAS 135729-62-3 Ubunyulu > 99.0% (HPLC) (T) API Factory
Ubonelelo ngezoRhwebo iPalonosetron Hydrochloride kunye nabaPhakathi abaNxulumeneyo:
(S) -1,2,3,4-Tetrahydro-1-Naphthoic Acid CAS: 85977-52-2
(R)-1,2,3,4-Tetrahedro-1-Naphthoic Acid CAS: 23357-47-3
(S)-3-Aminoquinuclidine Dihydrochloride CAS: 119904-90-4
I-3-Quinuclidinone Hydrochloride CAS: 1193-65-3
I-1-Naphthoic Acid CAS: 86-55-5
I-Palonosetron Hydrochloride CAS: 135729-62-3 API
Igama leMchiza | I-Palonosetron Hydrochloride |
Izithethantonye | IPalonosetron HCl;(S,S)-Palonosetron Hydrochloride;RS-25259;RS25259 197;(S)-2-((S)-Quinuclidin-3-yl)-2,3,3a,4,5,6-Hexahydro-1H-Benzo[de]isoquinolin-1-one Hydrochloride;(3aS)-2-(3S)-1-Azabicyclo[2.2.2]oct-3-yl-2,3,3a,4,5,6-Hexahydro-1H-benz[de]isoquinolin-1-one Hydrochloride ;IAloxi;I-Onicit |
Inombolo yeCAS | 135729-62-3 |
Inombolo yeCAT | RF-API03 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | C19H24N2O·HCl |
Ubunzima beMolekyuli | 332.87 |
Umqathango Omele Uphetshwe | Ubushushu Bubuthathaka |
Indawo yokunyibilika | 307℃ (ngoDisemba) |
Ukunyibilika emanzini | Inyibilika ngokupheleleyo emanzini |
Ukunyibilika | Kancinci kakhulu ukunyibilika kwi-Ethanol |
Ubushushu bokuthutha | Ubushushu obugciniwe |
I-COA kunye ne-MSDS | Iyafumaneka |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Umgubo weCrystalline oMhlophe okanye oMhlophe |
I-Palonosetron Hydrochloride | >99.0% (HPLC) (T) |
Ukujikeleziswa okuthe ngqo [α]20/D | -98.0°~-104.0° |
Ukuchongwa | Yongeza i-BiI7K4, Yenza i-Orenji ye-Orenji etyheli |
Ukuchongwa | I-TLC Iyangqinelana neNgcaciso yeNgcaciso |
Ukuchongwa | I-IR Iyangqinelana ne-IR esemgangathweni |
Ukuchongwa | Ukuchongwa njengeChloride |
Ukunyibilika | Inyibilika ngokukhululekileyo emanzini, inyibilika kancinane kwiMethanol, inyibilika kancinane kakhulu kwi-ethanol, ayinyibiliki kwi-acetone. |
Ukucaca kunye nombala wesisombululo | Max.Yellow No. 2 Standard Color Solution |
pH Vaule | 4.5~6.5 (10mg/ml) |
Izinto Eziyeleleneyo | |
iCompound A eyeleleneyo (NO) | <0.10% |
iCompound B eNxulumeneyo (Ene-NO) | <0.10% |
iCompound C enxulumeneyo (S,R) | <0.10% |
iCompound D enxulumeneyo (R,S) | <0.50% |
I-Palonosetron Enantiomer | <0.10% |
iCompound E eyeleleneyo (3-Ene) | <0.50% |
Ukungcola Okungachazwanga Okungatshatanga | <0.10% |
Izinyibilikisi ezishiyekileyo | |
I-Ethanol | <3000ppm |
Tetrahydrofuran | <5000ppm |
I-DMF | <880ppm |
IHexane eqhelekileyo | <290ppm |
Utywala beMethyl | <3000ppm |
Isopropanol | <5000ppm |
I-methylbenzene | <890ppm |
Amanzi | <0.30% |
Intsalela kwi-Ignition | <0.20% |
Ilahleko ekomisweni | <1.00% |
Iintsimbi ezinzima | <10ppm |
Umgangatho woVavanyo | I-United States Pharmacopoeia (USP);I-European Pharmacopoeia (EP) |
Ukusetyenziswa | Palonosetron Hydrochloride API;5-HT3 Umchasi;I-CINV |
Iphakheji: Ibhotile, Igubu lekhadibhodi, 25kg / Igubu, okanye ngokwemfuno yomthengi.
Ugcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma kunye nokuhlaselwa zizinambuzane.
I-Palonosetron Hydrochloride (i-CAS: 135729-62-3) iyeza lokuthintela isicaphucaphu kunye nokuhlanza, luhlobo olutsha olukhethiweyo oluphezulu, oluhambelana ne-5-HT3 i-receptor antagonist enokuthintela ukugabha iziko le-reflex peripheral neurons presynaptic 5-HT.I-receptor excitement ichaphazela ngokuthe ngqo inkqubo ye-nervous central kwi-5-HT.I-impulse receptor excitement eyenziwa yindima ye-vagal afferent nerve emva kommandla, ukuvimbela i-vagus nerve endings emathunjini, ukukhusela iimpawu kwi-5-HT.Indawo ye-receptor trigger zone inokunciphisa izehlo zesicaphucaphu kunye nokuhlanza.Embindini weklinikhi kunyango lwe-emetogenic ebukhali kakhulu ichemotherapy ebangela ukulibaziseka kwesicaphucaphu kunye nokugabha.Ngenxa yempembelelo yayo ephezulu yokunyanga, isiphumo esincinci, isiqingatha sobomi obude (malunga ne-40 h), idosi encinci, njalo njalo, iye yatsala ingqalelo enkulu.
Nge-1,2,3,4-Tetrahydro-1-Naphthoic Acid njengento yokuqala, ukuhlukana, ukuchithwa, ukunciphisa, i-cyclization, ityuwa ye-palonosetron hydrochloride granisetron.Izifundo zeklinikhi zibonise ukuba i-palonosetron ingasetyenziswa ngokukhuselekileyo kunye ne-corticosteroids, i-analgesics, i-antiemetics, i-antispasmodics kunye ne-anticholinergic drug njengezinto zokuqala, ukwahlukana, ukuchithwa, ukunciphisa, i-cyclization, ityuwa ye-palonosetron hydrochloride granisetron.